(While navigating through the site, please be sure to disable your pop-up blocker.)
Institute Research Investigator - ECLIPSE
Education
Required: Bachelor's degree in biology, biochemistry, molecular biology, cell biology, enzymology, pharmacology, chemistry or related field.
Preferred: Ph.D. in Immunology, Cancer Biology, Virology or a related discipline from an accredited university. BS/MS in biological sciences from an accredited university
Experience
Required: Six years experience of relevant research experience in laboratory With Master's degree, four years of required experience. With a PhD in a natural science or Medical degree, no experience required.
Preferred experience:
1. Application of relevant expertise in the areas of immunology, cancer biology, cell biology, genomics and drug discovery to project goals.
2. Proven track record of achievement either via peer reviewed publications, patents and/or presentations at national/international conferences.
3. Ability to plan, execute and interpret experimental data in a timely fashion.
4. The ability to prioritize and manage multiple experiments in a timely and resource effective manner for science-based go/no-go decision making.
5. Training in an oncology/immunology research laboratory and expertise in standard cell/molecular biology techniques.
6. An understanding of LIMS and/or prior experience with ELN is valued.
7. Ability to work well under pressure and drive personal and team objectives that impact critical timelines is expected.
8. A flexible, collaborative attitude is essential for this position.
It is the policy of The University of Texas MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law. http://www.mdanderson.org/about-us/legal-and-policy/legal-statements/eeo-affirmative-action.html